14 November 2022
ECO Animal Health Group plc
(the "Company" or the "Group") (AIM: EAH)
Change of Auditor
Following a competitive tender process overseen by the Group's Audit & Risk Committee, the Company announces the resignation of BDO LLP as auditor and the appointment, with immediate effect, of Haysmacintyre LLP as auditor for the financial year ending 31 March 2023. Haysmacintyre's re-appointment for the subsequent financial year will be subject to approval by shareholders at the next Annual General Meeting of the Company to be held in 2023.
The Group's Audit & Risk Committee decided to undertake a formal audit tender process following the end of the last financial period. BDO LLP has deposited with the Company a statement confirming that there are no matters to be brought to the attention of the Company's members or creditors.
For further information, please contact:
Contacts:
|
ECO Animal Health Group plc David Hallas (CEO) Christopher Wilks (CFO) |
|
|
IFC Advisory Graham Herring Zach Cohen |
020 3934 6630 |
|
Singer Capital Markets (Nominated Adviser & Joint Broker) Mark Taylor George Tzimas |
020 7496 3000 |
|
Investec (Joint Broker) Gary Clarence Brough Ransom Carlo Spingardi |
020 7597 5970 |
|
Peel Hunt LLP (Joint Broker) Dr Christopher Golden |
020 7418 8900 |
James Steel
|
Equity Development Hannah Crowe Matt Evans |
020 7065 2692 |
About ECO Animal Health
ECO Animal Health Group plc researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development ("R&D") for new products, particularly vaccines, and seeking to in-license new products